Background/Aims: Volume-regulated anion channels (VRACs) are of particular importance in regulating the cell volume (CV) and give rise to the swelling-activated Cl -current (I Cl,swell ), a main component driving global regulatory volume decrease (RVD) during cell swelling. Because I Cl,swell affects numerous CV-regulated processes like migration, we assume that its role is also indispensable for phagocytosis which requires local cell swelling. Noradrenaline (NA) modulates phagocytosis in macrophages and microglial cells, macrophage-related cells in the central nervous system. Therefore we evaluated whether NA modulates I Cl,swell and phagocytosis in microglia. Methods: Experiments were performed in murine microglial BV-2 and primary mouse microglial cells. Patch clamp experiments were performed in BV-2 cells using the amphotericin-perforated method to minimize cytosolic disturbances. Phagocytosis was quantified by scanning electron microscopy. Results: Following activation of I Cl,swell by a hypotonic bath solution, noradrenaline, as well as the β-adrenergic agonist isoproterenol, evoked a transient decrease of I Cl,swell . Repeated application of adrenergic agonists caused a decline of this electrical response. Application of the agonist of exchange protein directly activated by cAMP (Epac), 8-pCPT-2-O-Me-cAMP, or the protein kinase A inhibitor H89 caused a persistent suppression of I Cl,swell . When isoproterenol was added concomitantly with the hypotonic saline, I Cl,swell developed more rapidly compared to control conditions. Uptake of IgG-coated beads was suppressed by NA or H89 when quantified after 15 min of exposure.
Introduction
Noradrenaline (NA) modulates phagocytosis in microglial cells, resident macrophages in the central nervous system, as well as in macrophages in the peripheral tissue [1] [2] [3] [4] [5] . Interestingly, specific immune responses -e.g. activation and proliferation of macrophages and lymphocytes or release of cytokines -depend on the activation of distinct ion channels [6, 7] [for review see [8] [9] [10] [11] ]. In line with these observations, recent studies demonstrated that phagocytosis in microglial cells is related to the activation of a swelling-activated Cl -current, I Cl,swell [12, 13] and the Na + -dependent neutral amino acid transporter SNAT1, which mediates cell swelling upon substrate transport [14] . Whether I Cl,swell in microglia is modulated by adrenergic agonists is unknown.
Global regulatory cell volume decrease (RVD), which follows cell swelling, depends on activation of K + -and Cl -channels, whereas global cell volume regulatory volume increase (RVI), which follows cell shrinkage, requires Na + -influx pathways [15] [for review see [16] [17] [18] [19] [20] ]. Local subcellular volume regulatory processes contribute to lamellipodium formation in migrating cells [21] [22] [23] [24] [25] [26] [27] and engulfment pseudopodium formation in phagocytes [13] . In microglial cells, replacement of Na + by other cations or application of the Na + channel blocker tetrodotoxin attenuates phagocytosis [14] [for review see [28] ]. In addition, Cl -channel blockers impair phagocytosis in microglial cells [12, 13] . We suggest that in phagocytes like microglial cells, a Na + -influx promotes local swelling leading to the formation of a phagocytic cup at the contact area between the phagocyte and the particle, and that Cl -efflux prevents thickening of the pseudopodia to keep the membrane expansion locally [13, 14] . Thus, while at the tip of the crest of the engulfment pseudopodia a local influx of osmolytes and water promotes swelling, in its proximity an efflux of osmolytes and water causes shrinkage to constrain the local swelling [13] . Following local volume increase, the newly formed pouch is subsequently colonized by cytoskeletal elements to stabilize the engulfment pseudopodia. A similar line of arguments has been used for the interpretation of lamellipodia formation and cell migration [21] [22] [23] [24] [25] [26] [27] .
NA triggers cAMP-dependent signaling cascades [29] [30] [31] . The ubiquitous second messenger cAMP shows differences in its subcellular compartmentalization, time course and downstream signaling cascades, which could lead to diverse and even opposite physiological responses to the same agonist in immune cells. For example, an initial and transient cAMP elevation is required for T cell activation, whereas a sustained elevation of cAMP suppresses T cell activation [8] . The G protein-cAMP-dependent signaling cascade shows an early molecular dichotomy at the level of the cAMP-binding proteins, protein kinase A (PKA) and the exchange protein directly activated by cAMP (Epac). Because PKA and Epac are coupled to distinct signaling cascades, the dichotomy at the level of these effector proteins may also have consequences in the physiological response to cAMP elevating-agents. While the PKA signaling cascades include numerous phosphorylation steps, the Epac signaling cascades include small GTPases, phospholipases, as well as mitogen-and lipid-activated kinases [for review see [30] [31] [32] ]. In myeloid cells, cAMP-dependent pathways have been reported to increases or decreases phagocytosis [3] [4] [5] [33] [34] [35] [36] . In murine microglial cells, both application of the Epac-agonist 8-pCPT-2-O-Me-cAMP and suppression of PKA activity impair phagocytosis, indicating that the Epac-Rap pathway suppresses and the PKA-dependent phosphorylation enhances phagocytosis [5, 36] . Extracellular modulators, like NA, activate cAMP-dependent pathways [29] . In microglia noradrenergic agonists either increase or decrease phagocytosis [3, 5] . Among the ion channels, whose activities are modulated by PKA-as well as Epac-dependent processes are Cl -channels. In microglial cells, PKA activates a Cl -conductance [37] . In rat hepatocytes, the Epac agonist 8-pCPT-2-O-Me-cAMP activates a Cl -current, which has similar properties as the swelling-activated Cl -current [38] . Although a cAMP-PKA-dependent pathway activates a Cl -conductance in microglial cells [37] , we found that a cAMP/Epac-dependent pathways suppresses phagocytosis [5] . Thus, the Epacdependent suppression of phagocytosis resembles impairment of phagocytosis following blockade of Cl -channels in microglial cells [13] . In the present study we performed patch-clamp recordings and quantification of phagocytosis to estimate the association between cAMP-dependent modulation of the swelling-activated Cl -current I Cl,swell with cAMP-dependent phagocytosis. Our perforated patchclamp recordings revealed that both the Epac agonist 8-pCPT-2-O-Me-cAMP and the PKAantagonist H89 suppressed I Cl,swell , which indicates that PKA-dependent mechanisms increase I Cl,swell . Further, NA and the β-adrenergic agonist isoproterenol (ISOP) transiently suppressed osmotically-activated I Cl,swell . Compared to hypotonic solution alone, its simultaneous application with ISOP leads, however, to faster activation kinetics of the current, as indicated by a left-shift of the T 50 value (i.e. time to half-maximal current activation), hence indicating on the long term rather an activation than inhibition of I Cl,swell .
Materials and Methods

Chemicals and solutions
Unless stated otherwise, all chemicals were obtained from Sigma-Aldrich. The stock solution of (1) DL-norepinephrine hydrochloride (50 mg/mL) was prepared in ultrapure water, stored at -20°C; (2) (±)-propranolol hydrochloride (12 mg/4 mL) in dimethylsulfoxide (DMSO), stored at 4°C; (3) phentolamine hydrochloride (12 mg/4 mL) in ultrapure water, stored at -20°C; (4) N-[2-(p-Bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89) (5 mg/mL) in sterile ultrapure water, stored at 4°C; (5) yohimbine hydrochloride (10 mg/4 mL) in ultrapure water, stored at -20°C; (6) metaraminol (+)-bitartrate salt (200 mg/4 mL) in ultrapure water, stored at -20°C; (7) (R)-(−)-phenylephrine hydrochloride (20 mg/ mL) in ultrapure water, stored at 4°C; (8) DCPIP (4-[(2-Butyl-6,7-dichloro-2-cyclopentyl-2, 3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid) in ethanol, stored at -20°C. The stock solutions were diluted in serum-free DMEM or Ringer solution to appropriate concentrations for respective cell treatment. Working solutions were prepared immediately prior to their application.
Cell culture
Primary microglial cells were isolated from forebrains of 1-5 day-old wild-type C57 black 6J mice as previously described [17, 26, 39] . Animals were handled according to federal law. In brief, mice were decapitated followed by mechanical dissociation of cerebral cortices through centrifugation. Afterwards, the cell suspension was filtered using a 70 μm cell strainer (BD Biosciences) and cultivated in 0.1% poly-D-lysine (PDL)-coated 75 cm 2 culture flasks in Dulbecco's Modified Eagle's Medium (DMEM) containing 4.5 g/L glucose, L-glutamine and sodium pyruvate (PAA Laboratories) supplemented with 10% (v/v) FCS and 1% (v/v) penicillin/streptomycin (Gibco) at 37°C in a humidified atmosphere and 5% CO 2 . After 10-14 days in co-cultivation with adherent astrocytes, microglial cells were harvested via shaking from the astrocyte monolayer [40] for 3 h. The supernatant, containing >97% primary microglia was used for experiments.
Microglial BV-2 cells, generated by infecting primary mouse microglia with a v-raf/v-myconcogencarrying-retrovirus (J2) [41] , were grown and maintained in 25 cm 2 culture flasks in DMEM supplemented with 2.2 g/L glucose and 10% (v/v) fetal calf serum (FCS; Biochrom) at 37°C in a humidified atmosphere and 5% CO 2 and sub-cultured once a week. For experiments, BV-2 cells as well as primary microglial cells were seeded into Petri dishes on PDL-coated glass coverslips (diameter 12 mm) at a density of 8×10 4 cells/ ml and allowed to adhere overnight for up to 18 h. Following two washing steps, cells were left untreated or treated with the respective solvents (control) or with reagents as indicated.
Determination of phagocytosis by scanning electron microscopy
In each engulfment experiment, cells were cultured in 2 mL serum-free DMEM for 45 min. Cells were pretreated with NA, ISOP, phenylephrine, metaraminol, phentolamine, propranolol for 5 min, with 8-pCPT-2-O-Me-cAMP for 15 min and with H89 for 30 min. Then, cells were exposed to 4 μm IgG-coated hydrophobic microspheres (Invitrogen) in the absence or presence of adrenergic agonists, antagonists, 8-pCPT-2-O-MecAMP, or H89 for 15 min.
For Scanning electron microscopy cells were fixed after the respective treatments in 2.5% (v/v) glutaraldehyde (Agar Scientific Limited) in phosphate buffered saline (PBS; pH 7.2-7.4) for 1 h, rinsed four times with PBS for 1 h and subsequently dehydrated in a graded series of ethanol (50, 70, 80, 90, 96, 100% v/v) . Thereafter, cells were air-dried for two times using hexamethyldisilazane (HMDS) (Fluka/ Sigma-Aldrich). Coverslips were attached on pins and 12 times for 15 seconds sputter-coated with a 50 nm layer of gold using an Agar Sputter Coater. Samples were visualized with a Cambridge Stereoscan 250 scanning electron microscope (Cambridge Instruments). For evaluation of the engulfment experiments only the numbers of completely engulfed microspheres were used. Electrophysiology BV-2 cells were plated on 0.01% PDL-coated glass coverslips (diameter 12 mm) and cultured for at least 24 h in DMEM. Coverslips were transferred to an RC-25 recording chamber and mounted on a Nikon Eclipse inverted microscope. All experiments were performed at room temperature and were recorded in the whole-cell (ruptured or perforated) patch clamp mode. Ruptured whole-cell mode was achieved by applying a slight suction through the pipette whereas the perforated whole-cell configuration was achieved by adding 130 μM amphotericin B to the pipette solution. Recordings were started as soon as the serial resistance was below 30 MΩ for the perforated and below 10 MΩ for the ruptured configuration. Patch electrode resistances were 3-7 MΩ. After establishing the whole-cell configuration the cells were superfused with an isotonic extracellular solution and data were recorded using an EPC-10 amplifier controlled by PatchMaster software (HEKA). Cell membrane potential (V mem ) recordings were performed in the zerocurrent clamp mode and whole-cell currents were monitored using 500 ms voltage ramps from -100 mV to +100 mV. Ramps were elicited every 10 seconds and the holding potential between the ramps was kept at -70 mV. For V mem and whole-cell recordings the same intra-and extracellular solutions were used. The intracellular (pipette) solution contained (in mM): 70 K 2 SO 4 , 10 NaCl, 10 KCl, 4 MgCl 2 , 2 CaCl 2 , 5 HEPES free acid, 5 EGTA (249 mOsm/kg, pH 7.2 adjusted with KOH). The extracellular solution contained (in mM): 140 NaCl, 5.6 KCl, 2.5 CaCl 2 , 1.5 MgCl 2 , 10 HEPES free acid, 4.5 D-glucose, 5 mannitol (300 mOsm/kg, pH 7.4 adjusted with NaOH). Whole-cell Cl -currents were elicited using the same ramp protocol with a holding potential kept at 0 mV to avoid any voltage-activated currents. The intracellular solution for the Cl -current recordings contained (in mM): 100 CsCl, 5 MgCl 2 , 10 HEPES free acid, 11 EGTA, 65 D-(+)-raffinose, 2 MgATP (306 mOsm/kg, pH 7.2 adjusted with CsOH). The isosmotic extracellular solution contained (in mM): 100 NaCl, 2.5 CaCl 2 , 2.5 MgCl 2 , 10 HEPES free acid, 95 mannitol (302 mOsm/kg, pH 7.2 adjusted with NaOH). Swelling-activated Cl -currents (I Cl,swell ) were elicited by superfusion with a 70% hypoosmotic extracellular solution (210 mOsm/kg) obtained by omission of mannitol. Reagents like NA, ISOP, H89 and 8-pCPT-2-O-Me-cAMP were applied with a hyposmotic extracellular solution after reaching steady-state I Cl,swell . Bath solution exchange was performed with a valve-controlled gravity-driven perfusion system (ALA Scientific Instruments) at a flow rate of 3-5 mL/min. Osmolalities of intra-and extracellular solutions were measured using a vapor pressure osmometer (Wescor). The relative anion permeabilities were calculated as described elsewhere [42] .
Statistical analysis
All data are presented as mean±SEM (standard error of the means). Statistical analyses were performed using Prism 7 (GraphPad Software). Patch clamp data were analyzed with Fit-Master software (HEKA) and Igor Pro 6 (Wave Metrics). Exponential and sigmoidal fits were done using Igor Pro 6 and Prism 7, respectively. In phagocytosis-experiments, 200-300 cells were counted in randomly selected microscopic fields. Each experiment was repeated at least three times. Ordinary or repeated measures one-way ANOVA (Tukey's post-hoc test), paired or unpaired double-sided t-tests were used as applicable to test the levels of significance. Results were regarded as statistically significant at p<0.05. Graphs were created with GraphPad Prism 7 and Igor Pro 6. 
Results
Noradrenaline triggers a variety of intracellular signaling cascades [29] , which could be extenuated or even eliminated during whole-cell recordings when the cell is dialyzed with the pipette solution. Therefore, to minimize disturbances of intracellular signaling cascades during single-cell recordings, we monitored the membrane potential (V mem ) as well as ion currents during application of adrenergic agonists using the amphotericin B perforated patch-clamp technique.
Characteristics of I Cl,swell
Replacement of the isotonic by the hypotonic saline (210 mOsm/kg) induced a slowly developing outwardly rectifying current, I Cl,swell . Fig. 1 visualizes Cl -currents evoked either by voltage ramps or by voltage steps from -100 mV to +100 mV. The holding potential was kept at 0 mV to inactivate voltage-dependent K + -channels. We observed in the perforated patch recordings an outwardly rectifying current with a reversal potential at 0 mV and slight inactivation at strong positive potentials. To control extra-as well as intracellular ionic composition, we performed ruptured patch clamp experiments to evaluate the permeability of the I Cl,swell . Equimolar substitution of Cl -with I -and gluconate -increased and decreased the relative permeability, respectively (P I /P Cl =1.48±0.08, n=5; P gluc /P Cl =0.19±0.02, n=4). We also observed that the current was completely suppressed by the Cl -channel blocker DCPIB (10 µM; n=3; figure 1). In summary, the current is sensitive to (1) osmotic gradients, (2) substitution of Cl -with I -or gluc -, (3) the Cl -channel blocker DCPIB and (4) displays slight inactivation at strong positive potentials. Therefore this current fulfills major criteria of a swelling-activated Cl -current, I Cl,swell [13, 15, 18, 26, 43] .
Noradrenaline (NA) and isoproterenol (ISOP) transiently suppress I Cl,swell in microglial cells
Under isotonic conditions neither NA (1 µM) nor ISOP (1 µM) changed V mem or the basal ion currents, I Cl,basal (data not shown; NA: V mem n=5, I Cl,basal n=2; ISOP: V mem n=4, I Cl,basal n=10). In further experiments, cells were exposed to hypotonic conditions and NA was added when I Cl,swell had reached a plateau. As shown in figure 2 , application of the α-and β-adrenergic agonist, NA, induced a profound transient decrease of I Cl,swell by about 23%. Six out of 18 cells (33%) did not respond to 1 µM NA and were not included in the statistics (figures 2 A, B, C). The suppression of the current was dependent on the NA concentration ( figure 2 D) . Similarly, the β-adrenergic agonist ISOP transiently reduced I Cl,swell (figure 3 A, B, C). During continued hypotonic conditions the cells were refractory to the same stimulus. As shown in figures 2 and 3, removal of and repeated exposure to NA or ISOP during hypotonic conditions resulted in a reduction of the response size; i.e. compared to the first application response, the second one was either absent or diminished. Four out of four (100%) NA-exposed cells and seven out of eight ISOP-exposed cells (87%) did not reveal a detectable decrease of I Cl,swell during a second application of NA and ISOP. This indicates a sustained action of the adrenergic agonists on I Cl,swell . However, establishing isotonic conditions for a few minutes and re-addition of hypotonic saline re-established the responsiveness of the cells to the same adrenergic agonists, NA and ISOP, leading to a comparable transient reduction of I Cl,swell . The time courses of the I Cl,swell decrease-and recovery following application of NA or ISOP were similar. The time constants τ of the current decrease and recovery were 1.09±0.20 min and 3.56±0.76 min (n=4) for NA and 0.87±0.12 min and 3.06±0.51 min (n=5) for ISOP, respectively. These findings could indicate that β-adrenergic receptors are functionally connected to temporally segregated mutually inhibiting signaling pathways. Depending on the dominance of one of the signaling pathways, the ion current either increases or decreases. Two candidates of such a dichotomy are PKA and Epac. 
Isoproterenol (ISOP) evokes a rapid I Cl,swell development when co-applied with a hypotonic solution
In the above experiments, we added the adrenergic agonists after the development of I Cl,swell . Because I Cl,swell (1) showed a transient decrease following application of adrenergic agonists and (2) was larger compared to pre-application conditions following wash-out at least in some ISOP experiments, the long-lasting effect of adrenergic agonists could be an increase in I Cl,swell . Therefore, we exposed cells to hypotonic solution simultaneously with 1 µM ISOP. As shown in figure 4 , the time courses of activation of I Cl,swell differed between cells 
The Epac agonist 8-pCPT-2-O-Me-cAMP and the PKA-inhibitor H89 persistently suppress I Cl,swell
PKA as well as Epac, are potential targets for cAMP, which increases upon β-adrenergic stimulation. Therefore, we evaluated whether these cAMP-activated proteins affect I Cl,swell . Following the establishment of I Cl,swell , the cells were superfused with the PKA antagonist H89 (figure 5) or the Epac agonist 8-pCPT-2-O-Me-cAMP (figure 6). As shown in figure 5 , within a few seconds after H89 application the outward current of I Cl,swell at +100 mV decreased by 28±8% and the inward current at -100 mV decreased by 30±10% (n=10; two cells did not respond to H89 and were not included in the statistics). In contrast to NA and ISOP, H89 suppressed I Cl,swell as long as the drug was present. When applied for a second time, the cells did no longer respond to the PKA inhibitor. Fig. 6 shows that I Cl,swell is also sensitive to the Epac agonist 8-pCPT-2-O-Me-cAMP. Its addition to the hypotonic solution led to a permanent reduction of the outward current at +100 mV by 33±9% and the inward current at -100 mV by 39±9% (n=6; one cell did not respond to the Epac agonist and was not included in the statistics). Furthermore, I Cl,swell tended to be larger after wash-out of 8-pCPT-2-O-Me-cAMP at +100 mV (140±26%; n=4) and was significantly larger at -100 mV (158±24%; n=4). The elevated current was also insensitive to the Epac agonist when it was applied for the second time. Notably, the reversal potential of the outwardly rectifying current did not change when H89 or 8-pCPT-2-O-Me-cAMP was applied, suggesting that these agents do not affect the ion selectivity in addition to the Cl -conductance. Analysis of the time courses of the I Cl,swell suppression and recovery phases revealed single exponential functions. The time constants τ for the decreases were 1.32±0.18 min (n=3) and 1.91±0.64 min (n=3) for H89 and 8-pCPT-2-O-Me-cAMP, respectively. Recovery from I Cl,swell suppression following drug washout revealed a τ of 4.28±0.73 min (n=3) for H89 and of 4.29±0.31 min (n=3) for 8-pCPT-2-O-Me-cAMP.
Noradrenaline and the PKA inhibitor H89 impair phagocytosis in microglial cells
According to a proposed model of pseudopodium movement during phagocytosis, which involves I Cl,swell to regulate its cell volume [26] , and according to our electrophysiological observation that adrenergic agonists modulate I Cl,swell , adrenergic responses on phagocytosis are of interest. Uptake of IgG-coated microspheres by microglial cells at the single cell level was quantified using scanning electron microscopy. Figures 7 and 8 visualize that NA suppresses microsphere uptake in the pM-and nM range as well as above 1 µM. Because NA activates α-as well as β-adrenergic receptors [29] , we used α-adrenergic antagonists to isolate the contribution of β-adrenergic receptors to microsphere uptake. Yohimbine, a selective α2-adrenergic antagonist, suppressed microsphere uptake in the presence of 1 pM NA as well as in the presence of 1 µM NA. Phentolamine, an α1-and α2-adrenergic antagonist, decreased microsphere uptake in the presence of 1 µM NA, but not in the presence of 1 pM NA ( figure 7 D) . Surprisingly, metaraminol, an α1-and α2-adrenergic agonist, as well Each circle represents the current obtained every 10 seconds at -100 mV (inward currents, lower traces) and +100 mV (outward currents, upper traces). Dotted lines denote 95% confidence intervals. Data were fitted by a sigmoidal Boltzmann function which was used to calculate the time to reach the half-maximal current activation (T 50 ). (B) T 50 values for outward currents at +100 mV and inward currents at -100 mV in the absence (control, CO) and presence of 1 µM ISOP. Data were determined from individual sigmoidal Boltzmann fits. Means±SEM. Asterisks denote significant difference from the respective control value. ** p<0.01. Figure 4 as phenylephrine, an α1-adrenergic agonist, significantly suppressed microsphere uptake ( figure 7D ). Phenylephrine also suppressed microsphere uptake in primary microglial cells ( figure 8B ). The β-adrenergic antagonist propranolol did not affect microsphere uptake in the presence of 1 pM NA, but it decreased it in the presence of 1 µM and 10 µM NA ( figure  7E ). The PKA inhibitor H89, suppressed microsphere uptake in BV-2 cells ( figure 7F ), indicating that a basal PKA activity facilitates microsphere uptake. Fig. 7F visualizes the additive inhibitory effect of NA, phentolamine and H89 on the suppression of microsphere uptake. Surprisingly, we found a similar additive effect of phentolamine and H89 when NA was not applied to the cells. 
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Discussion
Our findings suggest that NA modulates I Cl,swell through two distinct cAMP-dependent pathways. First, adrenergic agonists suppress I Cl,swell by a cAMP-Epac-dependent pathway. Second, adrenergic agonists enhance I Cl,swell by a cAMP-PKA-dependent pathway. According to our phagocytosis experiments, we suggest an adrenergic-cAMP-Epac-dependent pathway in an early phase, evidenced by a decrease in particle uptake as shown earlier [5] . In a later phase of phagocytosis, we assume an adrenergic-cAMP-PKA-dependent pathway.
Modulation of I Cl,swell by cAMP-dependent processes I Cl,swell is an ubiquitous anion current in immune cells. Its classical signatures are activation by cell swelling and dependence on intracellular ATP. ATP is required for activation and maintenance of I Cl,swell [15, 44, 45] . Whether ATP or one of its metabolites directly or indirectly affects I Cl,swell is unknown. Presumably, G-proteins are not involved in I Cl,swell activation in microglial cells, because intracellular dialysis of these cells with the non-hydrolysable G-protein activating nucleotide GTPγS had no significant effect on I Cl,swell or NA and phentolamine (α1-and α2-adrenergic antagonist) as well as application of metaraminol (α1-and α2-adrenergic agonist) and phenylephrine (α1-adrenergic agonist) in the absence (control, CO) and presence of adrenergic agonists (noradrenaline, NA; metaraminol, MET; phenylephrine, PHE) and/or antagonists (Yohimbine, Phentolamine). One-way ANOVA revealed significant differences between control and most treatment conditions (*). Pairwise comparison revealed significant differences between 1 pM NA and co-application of NA and yohimbine, 1 µM NA and co-application of NA and yohimbine, as well as 1 µM NA and co-application of NA and phentolamine (#). (E) Co-application of NA and propranolol (β-adrenergic antagonist). One-way ANOVA revealed significant differences if compared to control (*) or propranolol treatment (#). Pairwise t-test showed a significant difference between 10 µM NA and co-application of NA and propranolol. Comparison of NA (1 pM or 10 µM) alone and NA in the presence of propranolol is indicated by $. (F) Co-application of H89 (PKA antagonist) and phentolamine. One-way ANOVA revealed significant differences when compared to control (*) or H89 treatment (#). Means±SEM; * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 denote significant difference when compared to control [white bar]; # p<0.05, ## p<0.01, ### p<0.001 denote significant difference when compared to phentolamine [PHE; dark grey bar]); $ p<0.05, $$ p<0.01, denote significant difference when compared to 1 µM NA alone. activation in hypo-osmotic conditions [44] . However, swelling of S49 mouse lymphoma cells in hypotonic medium increases adenylate cyclase activity in a G-protein-independent pathway [46] . Further, Ca
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-and bicarbonate ions regulate the soluble adenylyl cyclase [for review sees [31] ]. Because VRAC channels, which give rise to I Cl,swell , are also permeable to bicarbonate [47] , a mutual interaction between soluble adenylyl cyclase and ion channels is conceivable. However, a few studies even demonstrate that a cAMP-PKA-dependent pathway activates a Cl -current in immune cells, which shows similar properties to an osmoticallyactivated I Cl,swell , but is activated under isotonic conditions [37, 48] . Dialysis of BV-2 cells with cAMP or with the catalytic subunit of PKA in the pipette solution activates an outwardly rectifying Cl -current in isotonic conditions [37] . Both, the cAMP-dependent-as well as the PKA-dependent Cl -current are sensitive to the Cl -channel blockers NPPB and flufenamic acid [37] . A similar cAMP-dependent modulation of a Cl -current has been shown in hepatocytes, where a glucagon-cAMP-Epac-dependent pathway activates a Cl -current resembling I Cl,swell [49] . Thus, in addition to the classical hallmarks of I Cl,swell , the present and a previous study suggest that I Cl,swell is modulated by cAMP-dependent pathways [37] . Moreover, it has recently been shown, that I Cl,swell of human atrial myocytes is augmented by NA, an effect mimicked by the Epac agonist 8-pCPT-2-O-Me-cAMP and inhibited by an Epac antagonist, thus implying that the effect of NA is mediated by an Epac-dependent pathway in these cells [50] . This contrasts the finding of our present study showing an inhibition of I Cl,swell by NA and 8-pCPT-2-O-Me-cAMP. The reason(s) for this discrepancy is (are) currently unclear but may be due to cell type-and/or species-specific differences, and eventually also due to the technical approach (ruptured vs. perforated whole-cell recordings).
Noradrenergic agonists elevate cAMP in microglial cells [5] . In general, a β-adrenoceptor-G S -adenylyl cyclase-dependent increase in cAMP activates the cAMP-binding proteins PKA and Epac [for review see [29, 31, 32, 51] ]. These proteins accumulate at A-kinase anchoring proteins (AKAPs), which are attracted to β-adrenoceptors [for review see [32] ]. In our perforated patch clamp experiments on microglial cells, noradrenergic agonists do not affect the Cl -conductance under isotonic conditions (I Cl,basal ). However, these agonists [52] [for review see [53] ].
Noradrenaline, I Cl,swell and phagocytosis in microglia
The discussion, whether catecholamines suppress or enhance inflammatory processes is controversial [3, [54] [55] [56] [57] [58] [for review see [59] ]. Cell volume regulatory processes have been considered to contribute to migration and phagocytosis [13, 21-25, 27, 60, 61] . Both processes are relevant in immune responses. Cellular migration contributes to the deployment of macrophages from lymphoid tissue to the site of inflammation and phagocytosis removes pathogenic particles. Enhancement or suppression of I Cl,swell is a ubiquitous modulatory mechanism of RVD in many cell types [for review see [17, 18, 20, 62] ]. Blockade of I Cl,swell in microglial cells impairs the formation of lamellipodia and engulfment pseudopodia as well as ramifications [9, 13, 26] .
In the present study, we demonstrate that I Cl,swell is sensitive to cAMP-elevating adrenergic stimulation. In a previous study, we described that the β-adrenergic agonist ISOP, as well as cAMP-elevating agents, like the adenylyl cyclase activator forskolin and the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX), decrease phagocytosis in microglial cells [5] . This observation is in agreement with reports showing an association between an increase in cAMP and a decrease in phagocytosis in alveolar macrophages [33] , in macrophages differentiated in vitro from human peripheral monocytes [34] , in the human monoblast cell line (U937) [35] and murine microglia [4, 36] . In contrast to these observations, Heneka and co-workers found that NA stimulates phagocytosis in microglia [3] . The difference between our observation and those from Heneka and co-workers could be related to (1) the time of exposure to cAMP-elevating agents (15 minutes in our study versus four hours), (2) the target of phagocytosis (IgG-labeled microspheres versus fibrillary fluorescent-labeled Aβ ) and (3) the method of quantification (scanning electron microscopy versus FACScan). Previous studies have demonstrated that cAMP-dependent suppression of phagocytosis involves Epac [5] as well as PKA [34, 36] . Because we observed that an Epac-dependent pathway suppresses I Cl,swell (present study) and that Cl -channel blockers impair phagocytosis in microglial cells [13] , we suggest that a cAMP-Epac-dependent pathway contributes to a NA-and ISOP-associated suppression of phagocytosis in microglial cells. Because the PKA-blocker H89 suppresses I Cl,swell as well as phagocytosis, we suggest that a cAMP-PKA-dependent pathway supports phagocytosis. In the present as well as in a previous study [5] , we observed that NA, the β-adrenergic agonist ISOP, the α-adrenergic agonists phenylephrine (α1-adrenergic agonist) and metaraminol (α1-and α2-adrenergic agonist) suppress phagocytosis. Puzzling, the β-adrenergic antagonist, propranolol, and the α-adrenergic antagonists yohimbine (α2-adrenergic antagonist) and phentolamine (α1-and α 2 -adrenergic antagonist), further enhance NA-induced suppression of phagocytosis (present study). The observations that different messengers evoke different physiological responses using the same second messenger, i.e. cAMP, could be related to the spatial and temporal compartmentalization of the cAMP-response [for review see [31] ]. Thus, facilitation as well as suppression of phagocytosis could be related to an increase in cAMP. In a shortterm modulation of phagocytosis, a cAMP-Epac-dependent pathway dominates and impairs phagocytosis, whereas in a long-term modulation a cAMP-PKA-dependent pathway could dominate and facilitate phagocytosis. Alternatively, the spatial distribution of I Cl,swell enhancing and suppressing cAMP-dependent factors along the proximal distal axis of a phagocytic cup could coordinate particle engulfment. If both cAMP-dependent pathways are activated simultaneously, the formation of a phagocytic cup is impaired. Accordingly, simultaneous application of α-and β-adrenergic agonists or antagonists could impair particle uptake by activating overlapping cAMP-dependent pathways simultaneously. The present findings may explain the controversial observations of NA on physiological properties of immune cells. Depending on the dominance of either a cAMP-Epac-or a cAMP-PKA-dependent pathway, opposing observations on migration, phagocytosis or additional immunological functions may be the consequence. In a physiological context, the time course of NA release or of removal of NA from the extracellular environment may affect the immunological response: oscillatory or pulsatile release of NA may favor a cAMP-Epacdependent pathway, whereas a chronic or tonic release may favor a cAMP-PKA-dependent pathway.
Conclusion
In summary, this study provides strong evidence that the β-adrenergic stimulation of microglial BV-2 cells triggers a cAMP-Epac-dependent-and cAMP-PKA-dependent cascade which affects phagocytosis via modulation of the swelling-activated Cl -current, I Cl,swell ( figure  9) . 
Figure 9
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